Drugs / Refresh Endura
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT00824811 | Jun 2009 → ? | excessive tearing | M.D. Anderson Cancer Center | Withdrawn | No outcome recorded Stop: Enrollment |
| Comparator or background therapy3 trials | ||||||
| Phase 2 | NCT00611403 Comparator | Dec 2007 → Dec 2008 | dry eye syndrome | Allergan | Completed | No outcome recorded |
| Phase 4 | NCT02004067 Comparator | Jan 2013 → Aug 2016 | Sjogren syndrome, dry eye syndrome | Federal University of São Paulo | Completed | No outcome recorded |
| Phase 4 | NCT00348335 Comparator | Jun 2006 → Sep 2007 | rosacea | Ophthalmic Consultants of Long Island | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Refresh Endura | “with that of Refresh Endura for the treatment of the signs and symptoms of ocular rosacea” NCT00348335 ↗ |